How Would Authorizing Medicare to Cover Anti-Obesity Medications Affect the Federal Budget?

Congressional Budget Office

No 60441, Reports from Congressional Budget Office

Abstract: Treatment with certain anti-obesity medications (AOMs) has been shown to lead to significant weight loss and improved health when recipients use the drugs consistently and at the prescribed time intervals. Currently, Medicare is prohibited by law from covering medications for weight management as part of the standard prescription drug benefit.

JEL-codes: H51 H60 H68 I12 I13 I18 (search for similar items in EconPapers)
Date: 2024-10-08
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.cbo.gov/system/files/2024-10/60441-medicare-coverage-obesity.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cbo:report:60441

Access Statistics for this paper

More papers in Reports from Congressional Budget Office Contact information at EDIRC.
Bibliographic data for series maintained by ().